All Stories

  1. Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohort
  2. The burden beyond the heart: educational challenges in children with congenital heart disease
  3. Cardiopulmonary exercise testing unmasks right ventricular failure in pulmonary arterial hypertension risk stratification: time to reframe the role of the 6-minute walk test?
  4. Advancing patient-centred care in complex congenital heart disease: the need for disease-specific long-term health-related quality of life tools
  5. Case report: a thrombus to remember: a case of warfarin non-compliance in a total cavopulmonary circulation patient
  6. Treat-and-repair: a simple but powerful term for a complex multimodal approach in patients with pulmonary arterial hypertension associated with congenital heart disease
  7. Infective endocarditis: Awareness, knowledge gaps and behaviours amongst adults with congenital heart disease
  8. Pregnancy in women with a Fontan circulation: Short and long-term outcomes
  9. Safety, tolerability, and efficacy of an in‐class combination therapy switch from bosentan plus sildenafil to ambrisentan plus tadalafil in children with pulmonary arterial hypertension
  10. Cardiac catheterization in pulmonary arterial hypertension: Tips and tricks to enhance diagnosis and guide therapy
  11. Long-term functional outcomes after the one-and-a-half ventricle repair: still a good option for selected patients
  12. Comparative prognostic value of echocardiographic parameters of the subpulmonary left ventricle in adults with a systemic right ventricle
  13. Pulmonary arterial hypertension related to congenital heart disease with a left-to-right shunt: phenotypic spectrum and approach to management
  14. The state of adult congenital heart disease training from the trainee perspective: a call for action
  15. Understanding the interface between physical and mental health in adults with congenital heart disease
  16. Improved prognostication using the inferior vena cava collapsibility index: A tool validated for adults with congenital heart disease
  17. Morbidity and mortality in adults with a Fontan circulation beyond the fourth decade of life
  18. Peripheral pulmonary artery stenosis in adults: a novel type of pulmonary vascular disease with a strong genetic background
  19. Pulmonary arterial hypertension in congenital heart disease
  20. Repair of Aortic Regurgitation in Young Adults: Sooner Rather Than Later
  21. Prognostic significance of subpulmonary left ventricular size and function in patients with a systemic right ventricle
  22. Management of pulmonary arterial hypertension during pregnancy
  23. Advanced heart failure in adult congenital heart disease: the role of renal dysfunction in management and outcomes
  24. Transition to adult care of young people with congenital heart disease: impact of a service on knowledge and self-care skills and correlates of a successful transition
  25. Transcatheter pulmonary valve implantation: An option for the few becoming an option for the many
  26. Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
  27. Paediatric pulmonary arterial hypertension following congenital heart defect repair: enhanced risk stratification and outcomes in a national cohort
  28. Correlation between right ventricular dysfunction and plasma protein profile in pulmonary hypertension
  29. Rationale, design and methodology of APPROACH-IS II: International study of patient-reported outcomes and frailty phenotyping in adults with congenital heart disease
  30. Training to care for adults with congenital heart disease in the USA and Europe
  31. Twenty-year experience and outcomes in a National Pediatric Pulmonary Hypertension Service
  32. Physiology of the normal heart
  33. Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom
  34. Prognostic implications of pulmonary wave reflection and reservoir pressure in patients with pulmonary hypertension
  35. Cardiopulmonary exercise testing in congenital heart disease: towards serial testing as part of long-term follow-up
  36. Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation
  37. Fluid challenge and balloon occlusion testing in patients with atrial septal defects
  38. Systemic microangiopathy in Eisenmenger syndrome – The missing link?
  39. Safety of physical sports and exercise in ACHD
  40. Enhanced Assessment of Perioperative Mortality Risk in Adults With Congenital Heart Disease
  41. Ultra‐Fast‐Track Extubation in Adult Congenital Heart Surgery
  42. Preventing disease progression in Eisenmenger syndrome
  43. Integrating patient-reported outcome measures in congenital heart disease care
  44. Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion
  45. Cardiac disease in Down Syndrome: literature review and international expert consensus in collaboration with Down Syndrome International (DSi)
  46. Non-cardiac surgery in congenital heart disease-associated pulmonary arterial hypertension: risk recognition and management
  47. PAH-CHD: transition to adulthood
  48. Often transferred, rarely transitioned: The current state of transition for young people with congenital heart disease
  49. Advanced therapies in Eisenmenger syndrome
  50. Pulmonary arterial hypertension associated with congenital heart disease after defect repair: the effect of pregnancy
  51. The investigation and diagnosis of pulmonary hypertension in adults with congenital heart disease
  52. Congenital Heart Disease and Pulmonary Hypertension
  53. Transcatheter Pulmonary Valve Prosthesis and Pregnancy
  54. Pulmonary artery denervation for pulmonary arterial hypertension
  55. Sex differences in hypertrophic cardiomyopathy: Time to tailor risk stratification and therapy?
  56. Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
  57. Modifiable risk factors in congenital heart disease: Education, transition, digital health and choice architecture
  58. Evaluating a strategy of PAH therapy pre-treatment in patients with atrial septal defects and pulmonary arterial hypertension to permit safe repair (“treat-and-repair”)
  59. The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome
  60. Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease
  61. CMR Right Ventricular-Pulmonary Arterial Coupling and Right Ventricular Trabecular Complexity: Prognostic in Lung Transplant Assessment?
  62. Heart or heart-lung transplantation for patients with congenital heart disease in England
  63. 32 The Impact of Haemoglobin Reduction on Short- and Long-Term Mortality Following Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction-analysis from a Real World Stemi Population
  64. Management of ST elevation myocardial infarction in pregnancy
  65. Non-electrolyte permeability of deoxygenated sickle cells compared